In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physicians Weigh Benefits, Hurdles Of ICD Risk Stratification

This article was originally published in The Gray Sheet

Executive Summary

Electrophysiologists hope that new risk stratification tools for sudden cardiac death can help sort out the most appropriate recipients of implantable cardioverter defibrillators, although barriers to adoption remain

You may also be interested in...



Heart Rhythm Society, Doctors Oppose National Coverage Of GE’s MTWA Test

GE Healthcare and Cambridge Heart are squaring off over rival methods of microvolt T-wave alternans testing

Heart Rhythm Society, Doctors Oppose National Coverage Of GE’s MTWA Test

GE Healthcare and Cambridge Heart are squaring off over rival methods of microvolt T-wave alternans testing

T-Wave Alternans ICD Screening May Gain Traction With St. Jude Pact

St. Jude Medical's endorsement of microvolt t-wave alternans testing under a co-marketing agreement with test maker Cambridge Heart will help accelerate adoption of the technology, which guides appropriate defibrillator patient selection, both companies say

Related Content

UsernamePublicRestriction

Register

MT023604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel